Catalog |
name |
Description |
price |
R-R-4165 |
BX471 hydrochloride CAS No.288262-96-4 |
BX471 hydrochloride (ZK-811752 hydrochloride)/CAS No.288262-96-4 is a potent, selective non-peptide CCR1 antagonist with Ki of 1 nM for human CCR1, and exhibits 250-fold selectivity for CCR1 over CCR2, CCR5 and CXCR4. |
price> |
R-R-4166 |
R243 CAS No.688352-84-3 |
R243/CAS No.688352-84-3 is a potent and selective CCR8 antagonist. R243 inhibits CCL1/CCR8 interaction and inhibits CCR8 signaling and chemotaxis. R243 has antinociceptive and anti-inflammatory effects. |
price> |
R-R-4167 |
GW 766994 CAS No.408303-43-5 |
GW 766994 (GW 994)/CAS No.408303-43-5 is a chemokine receptor-3 (CCR3) antagonist that is orally active and specific. GW 766994 has the potential for research into asthma and eosinophilic bronchitis. |
price> |
R-R-4168 |
C-021 CAS No.864289-85-0 |
C-021/CAS No.864289-85-0 is a potent CC chemokine receptor-4 (CCR4) antagonist. C-021 potently inhibits functional chemotaxis in human and mouse with IC50s of 140 nM and 39 nM, respectively. C-021 effectively prevents human CCL22-derived [35S]GTPγS from binding to the receptor with an IC50 of 18 nM. |
price> |
R-R-4169 |
Tivumecirnon CAS No.2174938-78-2 |
Tivumecirnon (FLX475)/CAS No.2174938-78-2 is an orally active CCR4 antagonist that blocks regulatory T cells from entering the tumor microenvironment, thereby reducing their interference with effective anti-tumor immune responses. Tivumecirnon has antitumor activity. |
price> |
R-R-4170 |
CCR2 antagonist 4 hydrochloride CAS No.1313730-14-1 |
CCR2 antagonist 4 hydrochloride (Teijin compound 1 hydrochloride)/CAS No.1313730-14-1 is a potent and specific CCR2 antagonist, with IC50s of 180 nM for CCR2b. CCR2 antagonist 4 hydrochloride potently inhibits MCP-1-induced chemotaxis with an IC50 of 24 nM. |
price> |
R-R-4171 |
K777 CAS No.233277-99-1 |
K777/CAS No.233277-99-1 is a potent, orally active and irreversible cysteine protease inhibitor. K777 is also a potent CYP3A4 inhibitor with an IC50 of 60 nM and a selective CCR4 antagonist featuring the potent chemotaxis inhibition. K777 irreversibly inhibits Cruzain, the major cysteine protease of Trypansoma cruzi, and cathepsins B and L. K777 is a broad-spectrum antiviral by targeting cathepsin-mediated cell entry. K777 inhibits SARS-CoV and EBOV pseudovirus entry with IC50 values of 0.68 nM and 0.87 nM, respectively. |
price> |
R-R-4172 |
Cenicriviroc Mesylate CAS No.497223-28-6 |
Cenicriviroc Mesylate (TAK-652 Mesylate)/CAS No.497223-28-6 is a dual CCR2/CCR5 antagonist, also inhibits both HIV-1 and HIV-2, and displays potent anti-inflammatory and antiinfective activity. |
price> |
R-R-4173 |
BMS-813160 CAS No.1286279-29-5 |
BMS-813160/CAS No.1286279-29-5 is a potent and selective CCR2/5 dual antagonist. BMS-813160 binds with CCR2 and CCR5 with IC50s of 6.2 and 3.6 nM, respectively. BMS-813160 can be used for the research of inflammation. |
price> |
R-C-2474 |
Flavoxate HCl CAS:3717-88-2 |
Flavoxate Hydrochloride(DW-61 Hydrochloride)is a muscarinic AChR antagonist used in various urinary syndromes and as an antispasmodic. |
price> |